SlowBull
The Business Brief FRIDAY, 4 SEPTEMBER 2026
← All stories
Markets

Revolution Medicines Got Its Breakthrough—What Moves It Next?

1 source ·1 article ·6h ago Revolution Medicines

FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus.

Covered by 1 outlet

Marketbeat 1

All coverage · 1 article

MarketBeat ·6h ago

Revolution Medicines Got Its Breakthrough—What Moves It Next?

FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus.